The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Open accessAbstract
Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition (EMT) and therefore presumably suppress the early phases of metastasis. Here, we determined that exposure of human colorectal cancer (CRC) cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron. Repression of MIR34A was required for IL-6-induced EMT and invasion. Furthermore, we identified the IL-6 receptor (IL-6R), which mediates IL-6-dependent STAT3 activation, as a conserved, direct miR-34a target. The resulting IL-6R/STAT3/miR-34a feedback loop was present in primary colorectal tumors as well as CRC, breast, and prostate cancer cell lines and associated with a mesenchymal phenotype. An active IL-6R/STAT3/miR-34a loop was necessary for EMT, invasion, and metastasis of CRC cell lines and was associated with nodal and distant metastasis in CRC patient samples. p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression. In Mir34a-deficient mice, colitis-associated intestinal tumors displayed upregulation of p-STAT3, IL-6R, and SNAIL and progressed to invasive carcinomas, which was not observed in WT animals. Collectively, our data indicate that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL-6R/STAT3/miR-34a feedback loop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-6 has been previously identified as a key cytokine that directly induces tumuor growth in CRC via STAT3 activation in IECs.12,15,46,47.”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED AND REPLACED: microRNA involvement in human cancer
Iorio, M. V., & Croce, C. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs140 · Cited by 577
RetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Jerry, 1993, Cancer Res., 53, 3374
Cited by
Sorted by citations
Items 301–400 of 754
Zhu, H., Lin, Y. H., & Liu, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12303 · Cited by 36
Is miR‐34a a Well‐equipped Swordsman to Conquer Temple of Molecular Oncology?
Farooqı, A. A., Fayyaz, S., Shatynska‐Mytsyk, I., Javed, Z., Jabeen, S., Yaylım, İ., Gasparri, M. L., & Panici, P. B. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12634 · Cited by 35
Wu, Y., Xu, X., Ma, L., Yi, Q., Sun, W., & Tang, L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.023 · Cited by 35
MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth
Phinney, B. B., Ray, A. L., Peretti, A. S., Jerman, S., Grim, C., Pinchuk, I. V., & Beswick, E. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01857 · Cited by 35
Varkaris, A. S., Κατσιαμπούρα, Α., Davis, J. S., Shah, N. N., Lam, M. S., Frias, R. L., Ivan, C., Shimizu, M., Morris, J. S., Menter, D. G., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0360-y · Cited by 35
El‐Daly, S. M., Omara, E. A. A., Hussein, J., Youness, E. R., & El-Khayat, Z. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101442 · Cited by 35
The role of miR‐34 in cancer drug resistance
Naghizadeh, S., Mohammadi, A., Duijf, P. H. G., Baradaran, B., Safarzadeh, E., Cho, W. C. S., & Mansoori, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29640 · Cited by 35
Bile reflux and hypopharyngeal cancer (Review)
Vageli, D. P., Doukas, S. G., Doukas, P. G., & Judson, B. L. (2021) · Oncology Reports · doi:10.3892/or.2021.8195 · Cited by 38
Role of noncoding RNAs and untranslated regions in cancer: A review
Zhang, Y., Yang, M.-W., Yang, S., & Hong, F. (2022) · Medicine · doi:10.1097/md.0000000000030045 · Cited by 38
Making sense of IL‐6 signalling cues in pathophysiology
Millrine, D., Jenkins, R. L., Hughes, S. T. O., & Jones, S. A. (2021) · FEBS Letters · doi:10.1002/1873-3468.14201 · Cited by 39
Liu, C., Rokavec, M., Huang, Z., & Hermeking, H. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06226-9 · Cited by 35
Self-citationJiao, P., Hou, J., Yao, M., Wu, J., & Ren, G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109164 · Cited by 34
Huang, H., Han, Y., Chen, Z., Pan, X., Yuan, P., Zhao, X., Zhu, H., Wang, J., Sun, X., & Shi, P. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15226 · Cited by 34
Song, Y., Li, Q., Liao, S., Zhong, K., Jin, Y., & Zeng, T. (2020) · Virology · doi:10.1016/j.virol.2020.05.011 · Cited by 34
Zhang, Y., Ren, H., Li, J., Xue, R., Liu, H., Zhu, Z., Pan, C.-Y., Lin, Y., Hu, A., Gou, P., et al. (2021) · PubMed Central · Cited by 34
microRNA-34 family: From mechanism to potential applications
Wang, C., Jia, Q., Guo, X., Li, K., Chen, W., Shen, Q., Xu, C., & Fu, Y. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106168 · Cited by 37
Shen, W., Yuan, Y., Zhao, M., Li, J., Xu, J., Lou, G., Zheng, J., Bu, S., Guo, J., & Xi, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5372-8 · Cited by 33
Liu, Z., Wang, H., Guan, L., Lai, C., Yu, W., & Lai, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14863 · Cited by 32
Messeha, S. S., Zarmouh, N. O., & Soliman, K. F. A. (2021) · Nutrients · doi:10.3390/nu13051718 · Cited by 34
MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development
Li, W., Liu, X., Dougherty, E. M., & Tang, D. G. (2022) · Cancers · doi:10.3390/cancers14184538 · Cited by 32
Chikh, A., Ferro, R., Abbott, J. J., Piñeiro, R., Buus, R., Iezzi, M., Ricci, F., Bergamaschi, D., Ostano, P., Chiorino, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7761 · Cited by 33
CTC-neutrophil interaction: A key driver and therapeutic target of cancer metastasis
Hu, C., Long, L., Lou, J., Leng, M., Yang, Q., Xu, X. M., & Zhou, X. W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117474 · Cited by 34
Wang, H., Sun, Q., Wu, Y., Wang, L., Zhou, C., Ma, W., Zhang, Y., Wang, S., & Zhang, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3461 · Cited by 32
Effect of dietary components on miRNA and colorectal carcinogenesis
Fadaka, A. O., Ojo, B. A., Adewale, O. B., Esho, T., & Pretorius, A. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0631-y · Cited by 34
LncRNA TUG1 promotes the development of osteosarcoma through RUNX2
Sheng, K., & Li, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7880 · Cited by 32
microRNAs as therapeutic targets in intestinal diseases
Wang, C., & Chen, J. (2019) · ExRNA · doi:10.1186/s41544-019-0026-9 · Cited by 33
Magidey, K., Cooper, T. J., Kveler, K., Normand, R., Zhang, T., Timaner, M., Raviv, Z., James, B. P., Gazit, R., Ronai, Z. A., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002856 · Cited by 34
Jeong, S. H., Son, E. S., Lee, Y. E., Kyung, S. Y., Park, J.-W., & Kim, S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00796-y · Cited by 35
Hung, C.-H., Wu, S., Yao, C.-I., Yeh, H.-H., Lin, C., Chu, C., Huang, T.-Y., Shen, M., Lin, C., & Su, W. (2024) · Nature Communications · doi:10.1038/s41467-024-51831-7 · Cited by 35
The Dual Roles of STAT3 in Ferroptosis: Mechanism, Regulation and Therapeutic Potential
Xie, J., Luo, D., Xing, P., & Ding, W. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s506964 · Cited by 32
Balancing STAT Activity as a Therapeutic Strategy
Polak, K. L., Chernosky, N. M., Smigiel, J. M., Tamagno, I., & Jackson, M. W. (2019) · Cancers · doi:10.3390/cancers11111716 · Cited by 30
Jiang, T., Gao, W., Lin, S.-J., Chen, H., Du, B., Liu, Q. L., Lin, X., & Chen, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.590492 · Cited by 31
RetractedLi, S., Wei, X., Zhan, X., He, J., Zeng, Y.-Q., Tian, X., Yuan, S., & Sun, L. (2020) · Cancers · doi:10.3390/cancers12123864 · Cited by 31
Guo, H., Zhuang, K., Ding, N., Hua, R., Tang, H., Wu, Y., Yuan, Z., Li, T., & He, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05328-0 · Cited by 31
Li, H., Rokavec, M., & Hermeking, H. (2015) · Oncotarget · doi:10.18632/oncotarget.4334 · Cited by 31
Self-citationMeshcheryakova, A., Svoboda, M., Tahir, A., Köfeler, H. C., Triebl, A., Mungenast, F., Heinze, G., Gerner, C., Philip Zimmermann, B., Jaritz, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7947 · Cited by 31
Ke, L., Xiang, Y., Xia, W., Yang, J., Yu, Y., Ye, Y., Hu, L., Guo, X., & Lv, X. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.01.004 · Cited by 31
The regulatory relationship between transcription factor STAT3 and noncoding RNA
Liu, S., Li, W., Liang, L., Zhou, Y., & Li, Y. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00521-1 · Cited by 30
Cui, H., Jin, Y., Wang, N., Liu, H., Shu, R.-L., Wang, J., Wang, X., Jia, B., Wang, Y., Bian, Y., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155509 · Cited by 30
Carstens, J. L., Lovisa, S., & Kalluri, R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75239 · Cited by 30
Tian, X., Zhang, H., Zhang, J., & Xing, J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12379 · Cited by 30
Luan, M., Chang, J., Pan, W., Chen, Y., Li, N., & Tang, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02494 · Cited by 31
Lee, C. H. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.031 · Cited by 30
Zhu, B., Zhao, L., Liu, Y., Jin, Y., Feng, J. Q., Zhao, F., Sun, J., Geng, R., & Wei, Y. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.012 · Cited by 30
EMT signaling: potential contribution of CRISPR/Cas gene editing
Mohammadinejad, R., Biagioni, A., Arunkumar, G., Shapiro, R. S., Chang, K., Sedeeq, M., Taiyab, A., Hashemabadi, M., Pardakhty, A., Mandegary, A., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03449-3 · Cited by 31
A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer
Kong, J., & Wang, W. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s234549 · Cited by 30
Zhang, T., Yang, J., Sun, Y., Song, J., Gao, D., Huang, S., Pang, A., Zhang, J., Wang, J., Wang, Y., et al. (2023) · Analytical Cellular Pathology · doi:10.1155/2023/8334881 · Cited by 31
Sun, L., Yu, J., Guinney, J., Qin, B., & Sinicrope, F. A. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0552 · Cited by 30
IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-β
Wang, H., Tang, F. R., Bian, E., Zhang, Y., Ji, X., Yang, Z., & Zhao, B. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05146-2 · Cited by 30
Liu, W., Qian, K., Wei, X., Deng, H., Zhao, B., Chen, Q., Zhang, J., & Liu, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5592 · Cited by 29
Rokavec, M., Bouznad, N., & Hermeking, H. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.02.003 · Cited by 29
Self-citationAggarwal, V., Tuli, H. S., Varol, M., Tuorkey, M. J., Sak, K., Parashar, N. C., Barwal, T. S., Sharma, U., Iqubal, A., Parashar, G., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103403 · Cited by 29
Hui-lin, Y., Karl, M. N., Wang, W., Starich, B., Tan, H., Kiemen, A. L., Pucsek, A. B., Kuo, Y., Russo, G. C., Pan, T., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.008 · Cited by 29
Duan, Q., Pang, C., Chang, N., Zhang, J., & Liu, W. (2016) · Oncology Reports · doi:10.3892/or.2016.4780 · Cited by 29
Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT
Liu, Y., Li, H., Ban, Z., Nai, M., Yang, L., Chen, Y., & Xu, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5578 · Cited by 29
Self-citation3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation
Peng, X., Chang, H., Chen, J., Zhang, Q., Yu, X., & Mi, M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3638-1 · Cited by 29
p53 mutation and deletion contribute to tumor immune evasion
Liu, S. M., Liu, T., Jiang, J., Guo, H., & Yang, R. L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1088455 · Cited by 31
The STAT3/SETDB2 axis dictates NF-κB–mediated inflammation in macrophages during wound repair
Mangum, K. D., denDekker, A. D., Li, Q., Tsoi, L. C., Joshi, A., Melvin, W. J., Wolf, S., Moon, J. Y., Audu, C. O., Shadiow, J., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179017 · Cited by 28
Teoh, S. L., & Das, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5357-7 · Cited by 29
SIX4 promotes metastasis through STAT3 activation in breast cancer.
Sun, X., Ma, J., Chen, Q., Hou, Z., Luo, X., Wang, G., Wang, J., Hu, J., & Cao, Z. (2020) · PubMed Central · Cited by 28
From inflammatory bowel disease to colorectal cancer: what’s the role of miRNAs?
Vaghari‐Tabari, M., Targhazeh, N., Moein, S., Qujeq, D., Alemi, F., Majidina, M., Younesi, S., Asemi, Z., & Yousefi, B. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02557-3 · Cited by 28
Xu, P., Sun, Y.-F., Fang, Y., Song, Q., Yan, Z., Chen, Y., Jiang, X., Fei, X., Zhao, Y. F., Lebœuf, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07964-5 · Cited by 28
Weng, W., Feng, J., Qin, H., Ma, Y., & Goel, A. (2015) · Future Oncology · doi:10.2217/fon.15.83 · Cited by 28
Lv, N., Li, C., Liu, X., Qi, C., & Wang, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.917128 · Cited by 27
Kawasaki, K., Kuboki, S., Furukawa, K., Takayashiki, T., Takano, S., & Ohtsuka, M. (2020) · Liver International · doi:10.1111/liv.14747 · Cited by 26
Chen, G., Han, N., Li, G., Li, X., Li, G., Li, Z., & Li, Q. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0296-3 · Cited by 27
Xu, C., Qin, M., Tan, L., Liu, S., & HUANG, J.-A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5165 · Cited by 27
Han, C., Sun, B., Zhao, X., Zhang, Y., Gu, Q., Liu, F., Zhao, N., & Wu, L. (2017) · Technology in Cancer Research & Treatment · doi:10.1177/1533034617742312 · Cited by 27
Doukas, S. G., Vageli, D. P., & Sasaki, C. T. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13591 · Cited by 27
Tian, T., Xie, X., Yi, W., Zhou, Y., Xu, Y., Wang, Z., Zhang, J., Lin, M., Zhang, R., Lv, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113362 · Cited by 27
Wang, C., Guo, J., Zhang, Y., Zhou, S., & Jiang, B. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10784-8 · Cited by 27
Evaluation of drug resistance for EGFR-TKIs in lung cancer via multicellular lung-on-a-chip
Tan, J., Zhu, L., Shi, J., Zhang, J., Kuang, J., Guo, Q., Zhu, X., Chen, Y., Zhou, C., & Gao, X. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106805 · Cited by 30
MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.
Li, T., Li, L., Dongshuang, L., Wang, S., & Sun, J. (2015) · Europe PMC (PubMed Central) · Cited by 26
Fang, K., Sideri, A., Law, I. K. M., Bakirtzi, K., Polytarchou, C., Iliopoulos, D., & Pothoulakis, C. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.06.008 · Cited by 26
Jin, D.-J., Fang, Y., Li, Z., Chen, Z., & Xiang, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3638 · Cited by 27
MicroRNAs and Inflammation in Colorectal Cancer
Josse, C., & Bours, V. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42059-2_3 · Cited by 26
Gowing, S. D., Chow, S. C., Cools‐Lartigue, J., Chen, C. B., Najmeh, S., Goodwin-Wilson, M., Jiang, H. Y., Bourdeau, F., Beauchamp, A., Angers, I., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.07.023 · Cited by 26
Gerlach, K., Popp, V., Wirtz, S., Al-Saifi, R., Gonzalez Acera, M., Atreya, R., Dregelies, T., Vieth, M., Fichtner-Feigl, S., McKenzie, A. N. J., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjac097 · Cited by 25
Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer
Wang, F., Ma, Y., Wang, H., & Qin, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.5593 · Cited by 26
Sasaki, C. T., Doukas, S. G., & Vageli, D. P. (2018) · Neoplasia · doi:10.1016/j.neo.2018.02.001 · Cited by 25
Nasr, R., Hammoud, M. S., Nassar, F. J., Mukherji, D., Shamseddine, A. I., & Temraz, S. N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071867 · Cited by 25
Assessing deep learning methods in cis -regulatory motif finding based on genomic sequencing data
Wang, Y., Zhang, S., Ma, A., Wang, C., Wu, Z., Xu, D., & Ma, Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab374 · Cited by 25
The impact of low serum cholinesterase levels on survival in patients with colorectal cancer
Takano, Y., Haruki, K., Tsukihara, S., Ito, D., Kanno, H., Son, K., Hanyu, N. N., & Eto, K. (2022) · International Journal of Colorectal Disease · doi:10.1007/s00384-022-04119-5 · Cited by 25
Wang, Y., Kang, J., Wang, R., Ramezani, K., Bonakdar, M., Moghimi, N., Salimi, M., Yao, Y., & Wang, K. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136545 · Cited by 25
Cui, G., Wang, Z., Liu, H., & Pang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057181 · Cited by 25
Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression
Farzam, O. R., Najafi, S., Amini, M. A., Rahimi, Z., Dabbaghipour, R., Zohdi, O., Shahgoli, G. A., Baradaran, B., & Akbari, B. (2024) · Cancer Cell International · doi:10.1186/s12935-023-03202-3 · Cited by 25
MicroRNA-mediated dynamic control of mucosal immunity
Park, E. J., Shimaoka, M., & Kiyono, H. (2017) · International Immunology · doi:10.1093/intimm/dxx019 · Cited by 26
Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma
Zhang, K., Pan, X., Zheng, S., Yingying, F., Zhang, Y., Sun, C., Li, Z., & Li, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.067 · Cited by 25
Yang, J., Liao, Y., Wang, B., Cui, L., Yu, X., Wu, F., Zhang, Y., Liu, R., & Yao, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216427 · Cited by 24
Schneiderová, M., Naccarati, A., Pardini, B., Rosa, F., Gaetano, C. D., Jirásková, K., Opattová, A., Levý, M., Veskrna, K., Veškrňová, V., et al. (2017) · Mutagenesis · doi:10.1093/mutage/gex026 · Cited by 24
Opposing Roles of Inter-α-Trypsin Inhibitor Heavy Chain 4 in Recurrent Pregnancy Loss
Li, L., Choi, B. C., Ryoo, J. E., Song, S.-J., Pei, C.-Z., Lee, K. Y., Paek, J., & Baek, K. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.029 · Cited by 24
Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis
Wang, Y., Wu, M., Lei, Z., Huang, M., Li, Z., Wang, L., Cao, Q., Han, D. H., Chang, Y., Chen, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0970-5 · Cited by 24
Junyi, R., Wang, X., Wei, G., & Meng, Y. (2020) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000608 · Cited by 24
miR-410 regulates apoptosis by targeting Bak1 in human colorectal cancer cells
Liu, C., Zhang, A., Cheng, L., & Gao, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5271 · Cited by 23
Gan, C., Li, Y., Yu, Y., Yu, X., Liu, H., Zhang, Q., Yin, W., Yu, L., & Ye, T. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115089 · Cited by 23
KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer
Sun, W., Hu, S., Zu, Y., & Deng, Y. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23072 · Cited by 22
Chen, P., Zhang, Z., Wu, J., Zheng, J., & Lin, F. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109992 · Cited by 23
Pan, B., Zheng, L., Liu, S., Fang, J., Lou, C., Hu, X., Ye, L., Lai, H., Gao, J., Zhang, Y., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01261-5 · Cited by 27
Gintoni, I., Vassiliou, S., Chrousos, G. P., & Yapijakis, C. (2023) · Genes · doi:10.3390/genes14081578 · Cited by 23
Lu, J.-H., Wei, H.-J., Peng, B., Chou, H.-H., Chen, W.-H., Liu, H., & Deng, W. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0163 · Cited by 23
Metadata
- Authors
- Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., Slotta-Huspenina, J., Bader, F. G., Greten, F. R., & Hermeking, H.
- Affiliations
- TUM Klinikum (DE)
- Pathologisches Institut (DE)
- Universitätsmedizin Göttingen (DE)
- German Cancer Research Center (DE)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-03-18
- Volume
- 124
- Issue
- 4
- Pages
- 1853-1867
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3973098
- OpenAlex
- W2104268053
- Cited by
- 753
- References
- 66
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 60 · 2023: 66 · 2022: 90 · 2021: 69 · 2020: 66 · 2019: 76 · 2018: 59 · 2017: 69 · 2016: 65 · 2015: 66 · 2014: 20
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- GRO (submittedVersion)
- Funders
- Johns Hopkins University (HCT116)
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Deutschen Konsortium für Translationale Krebsforschung
- FP7 Ideas: European Research Council (281967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- colorectal cancer, epithelial-mesenchymal transition, interleukin-6, IL-6 receptor, STAT3, miR-34a, feedback loops, tumor invasion, metastasis, p53, snails, microRNA regulation
- MeSH terms
- Snail Family Transcription Factors, Animals, Disease Models, Animal, Female, Humans, Male, Neoplasm Invasiveness, Neoplasm Metastasis, Transcription Factors, Colorectal Neoplasms, Mice, Knockout, Receptors, Interleukin-6, Feedback, Physiological, MicroRNAs, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review